Drug Trial Radar · NCT01019083
Studies of Immune Responses to Orally Administered Vaccines in Developing Country
Last checked: Nov 20, 2026Latest source record: Jul 12, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,016
Planned (sponsor's estimate)
Start
Feb 2008
Primary completion
Dec 2010
Study completion Dec 2010
Sponsor
- Lead sponsor
- International Centre for Diarrhoeal Disease Research, BangladeshAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Göteborg University
- First posted
- Nov 25, 2009
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Double (participant, investigator)
- Primary purpose
- Basic science
- Who can join
- All sexes, from 1 year, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The efficacy and immunogenicity of enteric vaccines have generally been found to be lower in children in the developed than in the developing countries. This has been observed with vaccines against cholera rotavirus, ETEC and typhoid vaccines. There are a number of factors that may contribute to such differences in vaccine "take rates" in children, e.g. breast feeding and nutritional status of the children might influence their immunogenicity and efficacy. Thus, breast feeding of newborn and young infants may adversely influence the immune response to vaccination, which might have more pronounced effect in developing than in developed countries. Breastfeeding has also been shown to interfere with the serum immune responses to rotavirus vaccine although this effect could be overcome by administering three rather than one dose of the oral rotavirus vaccine. Our recent study of Dukoral in Bangladeshi children aged 18 months or younger has shown that the response rates and the magnitude of responses improved when breast milk was temporarily withheld . Thus, administration of vaccines may have to be adjusted when given to breast fed children. Another factor that may affect the immunogenicity is the effect of zinc. Previous studies have shown that zinc enhances the immune response to cholera vaccine in participants \> 2 years of age , a recent study also observed a similar effect in infants. In this research project, we plan to study a number of different factors that might influence the immunogenicity of the two licensed oral model vaccines, specifically the inactivated killed oral cholera vaccine, Dukoral, and the live oral typhoid vaccine, Ty21a. We will also identify strategies that might improve the immunogenicity of the vaccines. The main objective of our study is to identify immunization regimens that may improve the immunogenicity of the vaccines in young children, which could be subsequently in field trials in Bangladesh and other developing countries. Specifically, we will determine if: (i) interventions identified to enhance immune responses to Dukoral, including zinc supplementation, could also enhance the immune responses to Ty21a; (ii) these two vaccines are able to induce both acute and memory B and T cell responses, (iii) treatment with antiparasitic drugs prior to immunization could modulate the immune responses to cholera and typhoid vaccines; and (iv) examine if arsenic exerts a suppressive effect on the immunogenicity of these vaccines.
Conditions
- Cholera
- Typhoid
Interventions
PlaceboDrug
Placebo will be given according to randomization list
PlaceboDrug
Placebo will be given according to randomization list
ControlOther
Control will be selected from the Arsenic non contaminated Area
Zinc SulphateDrug
Zinc Sulphate will be given according to randomization list
Albendazole and SecnidazoleDrug
Albendazole and Secnidazole will be given according to randomization list
ArsenicOther
Participant will be selected from the Arsenic Contaminated Area
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determine if the immunogenicity of typhoid (Vivotif) and cholera vaccine (Dukoral) in young children is influenced by the factors i. zinc supplementation ii. antiparasitic drugs and iii. relationship between serum arsenic and immune response to DukoralTime frame: 3 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Firdausi Qadri
Dhaka, Bangladesh
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.